Insider · CIK 0001226064

KANAYA SUSAN M

Reports to the SEC for 2 companies · MOUNTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001226064

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−19.2K sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−5,209 sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−87.8K sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−67.1K sh	—	—	0
2022-10-20	ChemoCentryx, Inc.D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−91.3K sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−72.8K sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Restricted Stock UnitD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−91K sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−51.5K sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−3,920 sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−2,198 sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−10.1K sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−71.3K sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−3,876 sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−25K sh	—	—	0
2022-10-20	ChemoCentryx, Inc.D Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−133K sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−25K sh	—	—	0
2022-10-20	ChemoCentryx, Inc.Stock OptionD Disposition to Issuer	Director, See Remarks	DDisposition to Issuer	−8,482 sh	—	—	0
2022-08-16	ChemoCentryx, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−19.9K sh	—	—	35,102
2022-08-16	ChemoCentryx, Inc.S Sale	Director, See Remarks	SSale	−19.9K sh	$50.95	−$1.01M	91,317
2022-08-16	ChemoCentryx, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+19.9K sh	$10.86	+$216K	111,215
2022-08-04	ChemoCentryx, Inc.S Sale	Director, See Remarks	SSale	−46.3K sh	$50.17	−$2.32M	91,317
2022-08-04	ChemoCentryx, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+31.7K sh	$6.62	+$210K	137,615
2022-08-04	ChemoCentryx, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+14.6K sh	$6.23	+$90.9K	105,900
2022-08-04	ChemoCentryx, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−14.6K sh	—	—	30,209
2022-08-04	ChemoCentryx, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−31.7K sh	—	—	76,702
2022-02-22	ChemoCentryx, Inc.Stock Option (right to buy)A Award	Director, See Remarks	AAward	+75.2K sh	—	—	75,200
2022-02-22	ChemoCentryx, Inc.Restricted Stock UnitsA Award	Director, See Remarks	AAward	+59.7K sh	—	—	59,700
2022-01-01	ChemoCentryx, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−10K sh	—	—	0
2022-01-01	ChemoCentryx, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−10.5K sh	—	—	20,934
2022-01-01	ChemoCentryx, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−10.3K sh	—	—	10,334
2022-01-01	ChemoCentryx, Inc.F Tax Payment	Director, See Remarks	FTax Payment	−16.8K sh	$36.41	−$613K	132,717
2022-01-01	ChemoCentryx, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+10.5K sh	—	—	149,564
2022-01-01	ChemoCentryx, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+10.3K sh	—	—	139,098
2022-01-01	ChemoCentryx, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+10K sh	—	—	128,765
2021-02-25	ChemoCentryx, Inc.Stock Option (right to buy)A Award	Director, See Remarks	AAward	+21.7K sh	—	—	21,700
2021-02-25	ChemoCentryx, Inc.Restricted Stock UnitsA Award	Director, See Remarks	AAward	+31.4K sh	—	—	31,400
2021-01-01	ChemoCentryx, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−10.3K sh	—	—	20,667
2021-01-01	ChemoCentryx, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−10K sh	—	—	10,000
2021-01-01	ChemoCentryx, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−10K sh	—	—	0
2021-01-01	ChemoCentryx, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+10.3K sh	—	—	135,263
2021-01-01	ChemoCentryx, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+10K sh	—	—	124,930
2021-01-01	ChemoCentryx, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+10K sh	—	—	114,930
2021-01-01	ChemoCentryx, Inc.F Tax Payment	Director, See Remarks	FTax Payment	−16.5K sh	$61.92	−$1.02M	118,765
2020-06-12	ChemoCentryx, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+30K sh	$8.19	+$246K	121,317
2020-06-12	ChemoCentryx, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−30K sh	—	—	67,132
2020-06-12	ChemoCentryx, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+20K sh	$11.02	+$220K	141,317
2020-06-12	ChemoCentryx, Inc.S Sale	Director, See Remarks	SSale	−50K sh	$64.58	−$3.23M	91,317
2020-06-12	ChemoCentryx, Inc.Stock Option (right to buy)M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	−20K sh	—	—	60,000
2020-06-03	ChemoCentryx, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+1,583 sh	$6.62	+$10.5K	104,930
2020-06-03	ChemoCentryx, Inc.M Exercise/Conversion	Director, See Remarks	MExercise/Conversion	+3,959 sh	$3.57	+$14.1K	98,139

Recent filings

Accepted (ET)
Oct 244
KANAYA SUSAN M0000899243-22-034081
SEC(opens sec.gov)
Aug 184
KANAYA SUSAN M0001209191-22-046662
SEC(opens sec.gov)

Companies

Address

C/O CHEMOCENTRYX, INC. 850 MAUDE AVENUE

MOUNTAIN VIEW, CA, 94043